ANTISENSE MODULATION OF CD36L1 EXPRESSION

Details for Australian Patent Application No. 2002357102 (hide)

Owner ISIS PHARMACEUTICALS, INC.

Inventors DOBIE, Kenneth, W.

Pub. Number AU-A-2002357102

PCT Number PCT/US02/39183

PCT Pub. Number WO2003/052062

Priority 10/024,396 18.12.01 US

Filing date 9 December 2002

Wipo publication date 30 June 2003

Event Publications

27 March 2003 Complete Application Filed

  Priority application(s): 10/024,396 18.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-A-2002357102

16 September 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002357103-BIOACTIVE SPINAL IMPLANTS AND METHOD OF MANUFACTURE THEREOF

2002357101-ANTISENSE MODULATION OF CD81 EXPRESSION